Search Results

Philips completes cancellation of 4.4 million shares

Royal Philips announced that it has completed the cancellation of 4,437,164 of its shares.

June 19, 2024

·

1 min read

Sino Biological’s Center for Bioprocessing (C4B) in Houston, TX

Sponsored

Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services

In October 2023, Sino Biological, Inc. opened its Center for Bioprocessing (C4B) in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.

September 9, 2024

·

3 min read

Art collage, coins, and arrow up on the red and paper background. Concept of business and financial growth.

IPO

Upstream Raises $255M IPO for Inflammatory Drugs; CAMP4 Nets $75M for RNA Work

Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease work, while CAMP4 Therapeutics picked up $75 million to develop RNA-targeting drugs.

October 11, 2024

·

1 min read

·

Annalee Armstrong

Pictured: Healthcare worker conducting an eye exam

Drug Development

4DMT Unveils More Positive Data for Wet AMD Candidate

Mid-stage data for 4D Molecular Therapeutics’ wet AMD drug 4D-150 show improvements in visual acuity, reduced injection rate and encouraging safety data.

July 17, 2024

·

2 min read

·

Tyler Patchen

Biotech Bay

4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geographic Atrophy

4D Molecular Therapeutics today announced U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug Application (IND) for 4D-175, an R100 vector-based intravitreal genetic medicine, for the treatment of patients with GA.

June 24, 2024

·

7 min read

Gene therapy

4DMT’S Gene Therapy for AMD Clears Phase II, Heads to Late-Stage Studies

4D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for annualized standard-of-care injections in patients with wet age-related macular degeneration.

September 19, 2024

·

2 min read

·

Tristan Manalac

Deals

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2024

X4 Pharmaceuticals today announced that, effective on May 31, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc.

June 3, 2024

·

1 min read

Press Releases

4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day

September 19, 2024

·

10 min read

Drug Development

4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients

4Moving Biotech, a spin-off of 4P-Pharma committed to developing first-in-class treatments to modify the natural course of knee osteoarthritis, announces the successful achievement of the Phase 1 Lasare trial in knee osteoarthritis patients using 4P004.

June 10, 2024

·

3 min read

BioMidwest

Humhealth Unveils Remote Patient Monitoring With Advanced 4G Device Configuration and 4G Watch

Humhealth, a leading provider of innovative remote care solutions, has the capability to integrate with an advanced 4G Telehealth Gateway Hub and 4G vital monitoring devices.

May 1, 2024

·

3 min read